Safety of biweekly α(1)-antitrypsin treatment in the RAPID programme

Administration of 120 mg·kg(−1) α(1)-antitrypsin on a biweekly basis was safe and well tolerated http://ow.ly/CVbz30lUBum

Detalles Bibliográficos
Autores principales: Greulich, Timm, Chlumsky, Jan, Wencker, Marion, Vit, Oliver, Fries, Michael, Chung, Thomas, Shebl, Amgad, Vogelmeier, Claus, Chapman, Kenneth R., McElvaney, Noel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557539/
https://www.ncbi.nlm.nih.gov/pubmed/30237305
http://dx.doi.org/10.1183/13993003.00897-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557539/
https://www.ncbi.nlm.nih.gov/pubmed/30237305
http://dx.doi.org/10.1183/13993003.00897-2018

Ejemplares similares